NCT04923828 Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections
| NCT ID | NCT04923828 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Fudan University |
| Condition | Severe Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-12-31 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-12-31 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate PICUs in major cities in China by establishing a high-quality standardized clinical database of PICU inpatients Incidence, fatality rate, pathogen distribution, anti-infective treatment of community-acquired/nosocomial infections in inpatients.
Eligibility Criteria
Inclusion Criteria: * PICU patients with severe infection Exclusion Criteria: * Non-infected patient
Contact & Investigator
Guoping Lu, Doctor
PRINCIPAL INVESTIGATOR
Children's Hospital of Fudan University
Frequently Asked Questions
Who can join the NCT04923828 clinical trial?
This trial is open to participants of all sexes, aged 1 Month or older, up to 16 Years, studying Severe Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04923828 currently recruiting?
Yes, NCT04923828 is actively recruiting participants. Contact the research team at 13788904150@163.com for enrollment information.
Where is the NCT04923828 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT04923828 clinical trial?
NCT04923828 is sponsored by Children's Hospital of Fudan University. The principal investigator is Guoping Lu, Doctor at Children's Hospital of Fudan University. The trial plans to enroll 2,000 participants.